DK266486A - Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse - Google Patents
Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK266486A DK266486A DK266486A DK266486A DK266486A DK 266486 A DK266486 A DK 266486A DK 266486 A DK266486 A DK 266486A DK 266486 A DK266486 A DK 266486A DK 266486 A DK266486 A DK 266486A
- Authority
- DK
- Denmark
- Prior art keywords
- hydraterally
- preparation
- addition salts
- quinoloncarboxylic
- acid esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3520295 | 1985-06-07 | ||
| DE19853525108 DE3525108A1 (de) | 1985-06-07 | 1985-07-13 | Antibakteriell wirksame chinoloncarbonsaeureester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK266486D0 DK266486D0 (da) | 1986-06-06 |
| DK266486A true DK266486A (da) | 1986-12-08 |
Family
ID=25832894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK266486A DK266486A (da) | 1985-06-07 | 1986-06-06 | Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0205029A3 (fr) |
| KR (1) | KR870000329A (fr) |
| CN (1) | CN86103954A (fr) |
| AU (1) | AU5760786A (fr) |
| DE (1) | DE3525108A1 (fr) |
| DK (1) | DK266486A (fr) |
| ES (4) | ES8800197A1 (fr) |
| FI (1) | FI862399A (fr) |
| GR (1) | GR861475B (fr) |
| HU (1) | HU195954B (fr) |
| IL (1) | IL79025A0 (fr) |
| NO (1) | NO862042L (fr) |
| PT (1) | PT82719B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60228479A (ja) * | 1984-04-26 | 1985-11-13 | Toyama Chem Co Ltd | １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩 |
| IE58742B1 (en) * | 1984-07-20 | 1993-11-05 | Warner Lambert Co | Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds |
| DE3508816A1 (de) * | 1985-01-10 | 1986-07-10 | Bayer Ag, 5090 Leverkusen | 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren |
| AU585995B2 (en) * | 1985-06-20 | 1989-06-29 | Daiichi Pharmaceutical Co., Ltd. | Optically active pyridobenzoxazine derivatives and intermediates thereof |
| DE3525335A1 (de) * | 1985-07-16 | 1987-01-22 | Bayer Ag | Embonate von chinoloncarbonsaeuren und ihren derivaten |
| EP0230053A3 (fr) * | 1986-01-17 | 1988-03-30 | American Cyanamid Company | Acides 7-(substitué)pipérazinyl-1-éthyl-6-fluoro-1,4-dihydro-4-oxo-3-quinoléine carboxyliques |
| FR2594439B1 (fr) * | 1986-02-19 | 1989-04-21 | Vetoquinol Sa | Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique |
| DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
| US4780468A (en) * | 1987-08-07 | 1988-10-25 | Warner-Lambert Company | 8-trifluoromethyl quinolones as antibacterial agents |
| US4889857A (en) * | 1987-10-12 | 1989-12-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Quinolonecarboxylic acid compounds and pharmaceutical use thereof |
| JPH0228178A (ja) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
| CA2001203C (fr) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Dithiocarbamoyl quinolones antimicrobiens |
| DE10108271A1 (de) | 2001-02-21 | 2002-08-22 | Schering Ag | Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons |
| ATE257468T1 (de) * | 2001-03-30 | 2004-01-15 | Dar Al Dawa Dev And Invest Co | Chinolin-4-on derivate und deren verwendung als antibiotika |
| CN101648960B (zh) * | 2009-09-04 | 2011-08-10 | 诚达药业股份有限公司 | 氧氟沙星的制备方法 |
| CN109422726B (zh) * | 2017-09-04 | 2022-10-28 | 华东理工大学 | CD47/SIRPα的阻断剂及其应用 |
| CN109942488A (zh) * | 2019-04-04 | 2019-06-28 | 山东省联合农药工业有限公司 | 一种喹啉羧酸酯类化合物及其制备方法与用途 |
| CN110563645B (zh) * | 2019-06-14 | 2021-03-30 | 山东省联合农药工业有限公司 | 一种喹诺酮类化合物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
| JPS5649382A (en) * | 1979-09-28 | 1981-05-02 | Dainippon Pharmaceut Co Ltd | 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt |
| JPS5762259A (en) * | 1980-09-05 | 1982-04-15 | Kyorin Pharmaceut Co Ltd | Preparation of substituted quinolinecarboxylic acid derivative |
| IL74244A (en) * | 1984-02-17 | 1988-06-30 | Warner Lambert Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| JPS60228479A (ja) * | 1984-04-26 | 1985-11-13 | Toyama Chem Co Ltd | １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩 |
| IT1213173B (it) * | 1984-06-04 | 1989-12-14 | Chiesi Farma Spa | Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche. |
| JPS6191183A (ja) * | 1984-10-11 | 1986-05-09 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| EP0181521A1 (fr) * | 1984-10-19 | 1986-05-21 | Otsuka Pharmaceutical Co., Ltd. | Composés d'acide 1-phényl substitué-4-oxo-3-quinoléine carboxylique |
| AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
| DE3608745A1 (de) * | 1985-07-24 | 1987-01-29 | Bayer Ag | Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin |
-
1985
- 1985-07-13 DE DE19853525108 patent/DE3525108A1/de not_active Withdrawn
-
1986
- 1986-05-20 AU AU57607/86A patent/AU5760786A/en not_active Abandoned
- 1986-05-22 NO NO862042A patent/NO862042L/no unknown
- 1986-05-27 EP EP86107154A patent/EP0205029A3/fr not_active Withdrawn
- 1986-06-04 IL IL79025A patent/IL79025A0/xx unknown
- 1986-06-05 PT PT82719A patent/PT82719B/pt unknown
- 1986-06-05 KR KR1019860004456A patent/KR870000329A/ko not_active IP Right Cessation
- 1986-06-05 FI FI862399A patent/FI862399A/fi not_active Application Discontinuation
- 1986-06-06 HU HU862413A patent/HU195954B/hu not_active IP Right Cessation
- 1986-06-06 DK DK266486A patent/DK266486A/da not_active Application Discontinuation
- 1986-06-06 GR GR861475A patent/GR861475B/el unknown
- 1986-06-06 ES ES555839A patent/ES8800197A1/es not_active Expired
- 1986-06-07 CN CN198686103954A patent/CN86103954A/zh active Pending
-
1987
- 1987-05-14 ES ES557549A patent/ES8900048A1/es not_active Expired
- 1987-05-14 ES ES557548A patent/ES8900215A1/es not_active Expired
- 1987-05-14 ES ES557550A patent/ES8802613A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT82719B (de) | 1988-05-03 |
| ES8800197A1 (es) | 1987-11-01 |
| IL79025A0 (en) | 1986-09-30 |
| ES555839A0 (es) | 1987-11-01 |
| HUT41736A (en) | 1987-05-28 |
| ES557549A0 (es) | 1988-11-16 |
| FI862399A (fi) | 1986-12-08 |
| EP0205029A2 (fr) | 1986-12-17 |
| GR861475B (en) | 1986-10-07 |
| AU5760786A (en) | 1986-12-11 |
| FI862399A0 (fi) | 1986-06-05 |
| DK266486D0 (da) | 1986-06-06 |
| ES557550A0 (es) | 1988-09-01 |
| CN86103954A (zh) | 1987-01-28 |
| ES557548A0 (es) | 1989-04-01 |
| EP0205029A3 (fr) | 1988-06-15 |
| KR870000329A (ko) | 1987-02-17 |
| HU195954B (en) | 1988-08-29 |
| ES8900215A1 (es) | 1989-04-01 |
| DE3525108A1 (de) | 1986-12-11 |
| ES8900048A1 (es) | 1988-11-16 |
| PT82719A (de) | 1986-07-01 |
| NO862042L (no) | 1986-12-08 |
| ES8802613A1 (es) | 1988-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK451887D0 (da) | Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse | |
| DK108586A (da) | Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
| DK266486A (da) | Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK374289A (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
| NO871526D0 (no) | Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. | |
| DK521986D0 (da) | Benzylaminderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som fungicider | |
| DK29287D0 (da) | 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse | |
| DK192788D0 (da) | Substituerede anilidderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK23687A (da) | Substituerede 4-amino-3-hydroxysmoersyrederivater og deres fremstilling | |
| DK165552C (da) | Carboxylsyreestere, deres fremstilling og anvendelse som insecticider | |
| DK179786D0 (da) | (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika | |
| DK192588D0 (da) | Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK238089A (da) | Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK299983D0 (da) | Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK527886A (da) | 2,3,4,6-tetrasubstituerede 1,4-dihydropyridin-5-carboxylsyrederivater samt deres fremstilling og anvendelse | |
| DK292086A (da) | 2-halogennicergolinderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK523289D0 (da) | 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse | |
| DK504386D0 (da) | Gonadoliberinanaloge og farmaceutisk acceptable syreadditionssalte, deres fremstilling og anvendelse | |
| DK291986A (da) | 10alfa-methoxy-6-methylergolinderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK586985D0 (da) | 2-pyridylthionophoshorsyreestere, deres fremstilling og anvendelse | |
| DK202986D0 (da) | Permethrinsyre-(triazolyl-alkyl)-estere, deres fremstilling og anvendelse | |
| DK404386D0 (da) | Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK300583A (da) | Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK453485A (da) | 1,2,3,4,6,7,12,1rb-octahydroindolo-(2,3-a)quinolizin-1-yl-alkancarboxylsyreamider og farmaceutisk anvendelige syreadditionssalte deraf,deres fremstilling og anvendelse | |
| NO871576L (no) | Anthranilsyrederivater og fremgangsmaate for deres fremstilling. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |